Navigation Links
Uninsured, others less likely to receive breast cancer test
Date:12/4/2007

ment was observed for Medicare patients under age 65 (OR 1.29, p<0.0001), while Medicaid patients and Medicare patients 65 and older were not significantly different from those with private insurance.

Patients who resided in zip codes with the lowest education levels were significantly more likely to receive no lymph node assessment compared to those from areas with the highest education levels (OR 1.13, p=0.0001). But the greatest disparities were observed by age group. Patients 62 to 72 years old were 1.1 times a likely to receive no axillary lymph assessment (p<0.01) compared to patients 50 and under, while the oldest patients (age 73 and older) were more than three times as likely (OR 3.30, p<0.0001) not to receive any assessment compared to those 50 and under.

These results indicate that significant disparities exist in receipt of axillary lymph node assessments among women with early stage breast cancer, said Dr. Halpern, American Cancer Society strategic director of health services research and study co-author. While treatment guidelines indicate that axillary lymph node assessment may be considered optional in certain patient groups, it remains a key component in determining stage, and thereby both prognosis and appropriate treatment options. Disparity in receipt of this procedure among underserved populations is therefore a concern and requires further study.


'/>"/>

Contact: David Sampson
david.sampson@cancer.org
American Cancer Society
Source:Eurekalert

Page: 1 2

Related medicine news :

1. FDA Warns of Codeine Risk for Some Nursing Mothers
2. Mothers Know Best: NFL Moms Team With Eddie George to Showcase a Better Way to a Healthier Lifestyle
3. Older Brothers Might Spur Kids Aggression
4. Terrell Herring Honored by Big Brothers Big Sisters
5. Hip size of mothers linked to breast cancer in daughters
6. The Current Recall of Boy Scouts of Americas Plastic Badges Does Not Affect Embroidered Insignia, Badges & Awards Produced by Lion Brothers Company Inc.
7. MADD, AMA, NTSB, IIHS and Others Launch Support 21 Coalition
8. Overweight mothers run greater risk of having hyperactive children
9. Childlessness Bothers Men More Than Women
10. Patients of Courage Transcend Physical Disfigurement, Help Others
11. HIV drug resistance risk in mothers reduced by combination of common drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...ed, "frozen lozenge" provides breakthrough method ..., Dec. 2 "A spoonful of sugar help... it just isn,t that easy. That,s why Insight Phar...e, frozen single-use packages that offer cooling, ...shest sore throats. , , Sucrets ICE is th...
(Date:12/2/2008)... For most people, family gatherings, ...he fun of the holiday season. Not so for those wit...d--social situations, reports the December 2008 is... Boston (Vocus) December 2, 2008 --...other social activities are part of the fun of the...
(Date:12/2/2008)...Dec. 2 EIN News has ann...g in-depth news on brain cancer. , , With n...e finding out that information is one of the key c...ding to the growing demand for accurate informatio...procedures and drugs to treat it, EIN News is intr...
(Date:12/2/2008)...orice, pancakes, among other products, home to sod...althDay News) -- There can be plenty of sodium -- ... health-friendly, and shoppers should know that lo...fat products. , That,s the finding of a report ...zine. , Researchers analyzed 37 common supermar...
Breaking Medicine News(10 mins):Health News:New Sucrets(R) ICE Cools Sore Throat Pain 2Health News:Easing Social Anxiety During the Holidays: Tips from Harvard Women's Health Watch 2Health News:EIN News Introduces 'Brain Cancer News Today'; Website Offers Information on Risk Factors, Treatment, Drugs 2Health News:High Salt Levels Common in Many Foods 2
... virtual reality simulation tools are making denti... if M. Cenk Cavusoglu has his // way, then this me...rform delicate surgeries in a risk-free manner. "...cause it reduces the learning time and allows stud...
...n Victoria have claimed that they have developed a...se two viruses in question can easily kill humans ...harge sheet against the viruses is that Hendra vir...minent Queensland racehorse trainer Vic Rail and 1...
...uncture, even sham acupuncture may be as effective...omparable level of treatment efficacy has been doc... results were obtained with respect to reduction i...with a diagnosis of migraine were included for the...
... Organization to investigate the possibility of bu...ks of bird flu//. They are already ready to invest... investigation with bird flu virus is already bein...ns in the House of Commons about the UK's prepared...
Other Medicine News:
(Date:12/2/2008)... -- Micromet, Inc. (Nasdaq: MITI ), a biopharmac...bodies for the treatment of cancer, inflammation a...s entered into an agreement expanding its Committe...e Capital Limited, a private investment group. Un...mmitted to provide up to $75 million of capital du...
(Date:12/1/2008)...as announced that an oral,presentation of prelim...al,trial of TG101348 in myeloproliferative diseas...n Society of Hematology (ASH) Meeting. , , ... Title: A Phase I Study of TG101348, ...K2-Selective Inhibitor, in Patients with, ...
(Date:12/1/2008)...-way switch that, if turned off, causes lymphatic ...lose their identity and become more like blood end...PRNewswire-USNewswire/ -- Scientists at St. Jude ...a certain differentiated cell type is so ready to ...expression of a gene called Prox1 to dissuade it...
(Date:12/1/2008)...cember 9 at 11:00 am ET to Discuss Phase 2 Study R...Calif., Dec. 1 Sunesis...rmaceutical company focused on the development and...oday announced new data from its studies of vorelo...ted during the 50th American Society of Hematology...
Breaking Medicine Technology:Micromet Expands Committed Equity Financing Facility to $75 Million 2Micromet Expands Committed Equity Financing Facility to $75 Million 3Micromet Expands Committed Equity Financing Facility to $75 Million 4Micromet Expands Committed Equity Financing Facility to $75 Million 5Micromet Expands Committed Equity Financing Facility to $75 Million 6Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3Trouble quitting 3F 3A A new Pitt Carnegie Mellon smoking study may reveal why 25790 1Trouble quitting 3F 3A A new Pitt Carnegie Mellon smoking study may reveal why 25790 2Scientists ID Pathway That Makes Antipsychotic Drugs Work 25788 1Scientists ID Pathway That Makes Antipsychotic Drugs Work 25788 2Satyam Launches Comprehensive Mobile Healthcare Program for Rural Indians 25785 1Satyam Launches Comprehensive Mobile Healthcare Program for Rural Indians 25785 2Satyam Launches Comprehensive Mobile Healthcare Program for Rural Indians 25785 3Satyam Launches Comprehensive Mobile Healthcare Program for Rural Indians 25785 4Satyam Launches Comprehensive Mobile Healthcare Program for Rural Indians 25785 5SIRIUS XM Radio Joins Stand Up To Cancer Campaign with Live Broadcast of Star Studded Just Stand Up Fundraising Event on September 5 25783 1SIRIUS XM Radio Joins Stand Up To Cancer Campaign with Live Broadcast of Star Studded Just Stand Up Fundraising Event on September 5 25783 2SIRIUS XM Radio Joins Stand Up To Cancer Campaign with Live Broadcast of Star Studded Just Stand Up Fundraising Event on September 5 25783 3SIRIUS XM Radio Joins Stand Up To Cancer Campaign with Live Broadcast of Star Studded Just Stand Up Fundraising Event on September 5 25783 4
...h 12, 2007--Inflazyme,Pharmaceuticals Ltd. (TSX: I...nary results of the Phase 2b CAPSICS study with,IP...nce between,patients who received drug or placebo....rge and consistent across a number of,the end-poin... its,external experts to determine if anything unt...
...r BLA filing for C1-inhibitor,replacement therapy,...- Lev,Pharmaceuticals, Inc. (Lev) today announced ...rial of C1-esterase inhibitor (C1-INH),for the acu...e,acute study, which is part of the company,s CHAN...anofiltration Generation,evaluating Efficacy), the...
Other Medicine Technology:Inflazyme Announces Outcome of Review of Phase 2b Asthma Study:,Potential Mitigating Factors Identified which Prevent Clear,Interpretation of Results 2Inflazyme Announces Outcome of Review of Phase 2b Asthma Study:,Potential Mitigating Factors Identified which Prevent Clear,Interpretation of Results 3Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 2Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 3Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 4Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 5
...feature-packed projectors ideal for any practice. ...for longer life -- up to 2,000 hours under typical...tial cost with an incandescent illumination system.... And both provide exceptionally even illumination...
...cal design and utilizes a multi-layered, multi-coa... producing a measurable 20% increase in optical re...lity of the Ultra Series also results in a 20% inc...of view and a 14% increase in depth of field. A si...
With the touch of a button, the Marco Encore Automatic Chair quickly reclines from an upright position to a fully horizontal, flat-table mode-or anywhere in between.
Both the Marco Keratometer I and Keratometer II are one position instruments for objectively measuring corneal curvature. The keratometer II has the added feature of internal readings for the presbyo
Medicine Products: